Table 1 Baseline and perioperative characteristics
Characteristics | Vp3 (N = 22) n (%) | Vp4 (N = 18) n (%) | p value |
|---|---|---|---|
Demographic | |||
Age, median (range), year | 55.0 (38–67) | 57.0 (31–68) | 0.682 |
Gender (male/female) | 19 (86.4)/ 3 (13.6) | 14 (77.8)/4 (22.2) | 0.680 |
Etiology, HBV, yes | 20 (90.9) | 15 (83.3) | 0.822 |
Anti-viral treatment, yes | 13 (59.1) | 10 (55.6) | 0.822 |
Liver cirrhosis, yes | 20 (90.9) | 15 (83.3) | 0.642 |
Baseline data | |||
Child–Pugh score (5/6) | 13 (59.1)/ 9 (40.9) | 14 (77.8)/ 4 (22.2) | 0.209 |
ECOG performance status = 0, yes | 22 (100.0) | 17 (94.4) | 0.450 |
Hemoglobin, median (range), g/L | 137.5 (114–171) | 145 (105–189) | 0.189 |
WBC count × 109/L, median (range) | 5.62 (2.29–10.45) | 5.75 (3.67–11.99) | 0.276 |
Platelet count × 109/L, median (range) | 142 (67–327) | 161 (79–312) | 0.779 |
AFP at baseline > 400 ng/ml, yes | 10 (45.5) | 11 (61.1) | 0.726 |
Tumor number (single/ multiple) | 14 (63.6)/ 8 (36.4) | 9 (50.0)/ 9 (50.0) | 0.385 |
Tumor diameter > 10 cm, yes | 12 (54.5) | 12 (66.7) | 0.436 |
Lymphatic metastasis, yes | 4 (18.2) | 7 (38.9) | 0.173 |
Perioperative data | |||
AFP before surgery > 400 ng/ml, yes | 2 (9.1) | 6 (33.3) | 0.110 |
Laparotomy operation | 19 (86.4) | 18 (100) | 0.238 |
Treatment cycle, median (range), time | 4.5 (3–23) | 5 (3–9) | 0.946 |
Types of hepatectomy (left/right/segmental) | 5 (22.7)/6 (27.3)/11 (50.0) | 4 (22.2)/8 (44.4)/6 (33.3) | 0.465 |
Hospital stay after surgery, median (range), day | 8.5 (5–33) | 9.5 (5–20) | 0.697 |
Surgical time, median (range), min | 265.5 (178–390) | 260 (180–405) | 0.697 |
Blood loss, median (range), mL | 375 (50–1000) | 575 (50–3000) | 0.058 |
Child–Pugh 5th days after surgery (5/6) | 15 (68.2)/7 (31.8) | 14 (77.8)/4 (22.2) | 0.377 |